BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35072291)

  • 1. Robust nonparametric integrative analysis to decipher heterogeneity and commonality across subgroups using sparse boosting.
    Li Z; Luo Z; Sun Y
    Stat Med; 2022 Apr; 41(9):1658-1687. PubMed ID: 35072291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrative sparse boosting analysis of cancer genomic commonality and difference.
    Sun Y; Sun Z; Jiang Y; Li Y; Ma S
    Stat Methods Med Res; 2020 May; 29(5):1325-1337. PubMed ID: 31282286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robust semiparametric gene-environment interaction analysis using sparse boosting.
    Wu M; Ma S
    Stat Med; 2019 Oct; 38(23):4625-4641. PubMed ID: 31359454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust structured heterogeneity analysis approach for high-dimensional data.
    Sun Y; Luo Z; Fan X
    Stat Med; 2022 Jul; 41(17):3229-3259. PubMed ID: 35460280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revealing genomic heterogeneity and commonality: A penalized integrative analysis approach accounting for the adjacency structure of measurements.
    Wang X; Jiang Y; Sun Y
    Genet Epidemiol; 2024 Apr; 48(3):114-140. PubMed ID: 38317326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cancer genomic markers via integrative sparse boosting.
    Huang Y; Huang J; Shia BC; Ma S
    Biostatistics; 2012 Jul; 13(3):509-22. PubMed ID: 22045909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of breast cancer prognosis markers using integrative sparse boosting.
    Ma S; Huang J; Xie Y; Yi N
    Methods Inf Med; 2012; 51(2):152-61. PubMed ID: 22344268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting similarity of model sparsity structures in integrative analysis of cancer genetic data.
    Huang Y; Liu J; Yi H; Shia BC; Ma S
    Stat Med; 2017 Feb; 36(3):509-559. PubMed ID: 27667129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric modeling of neural point processes via stochastic gradient boosting regression.
    Truccolo W; Donoghue JP
    Neural Comput; 2007 Mar; 19(3):672-705. PubMed ID: 17298229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sparse boosting for high-dimensional survival data with varying coefficients.
    Yue M; Li J; Ma S
    Stat Med; 2018 Feb; 37(5):789-800. PubMed ID: 29152776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Penalization Method for Estimating Heterogeneous Covariate Effects in Cancer Genomic Data.
    Luo Z; Zhang Y; Sun Y
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting gene-environment interactions: A penalized robust approach accounting for hierarchical structures.
    Wu C; Jiang Y; Ren J; Cui Y; Ma S
    Stat Med; 2018 Feb; 37(3):437-456. PubMed ID: 29034484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression-based heterogeneity analysis to identify overlapping subgroup structure in high-dimensional data.
    Luo Z; Yao X; Sun Y; Fan X
    Biom J; 2022 Aug; 64(6):1109-1141. PubMed ID: 35524586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiparametric integrative interaction analysis for non-small-cell lung cancer.
    Li Y; Wang F; Li R; Sun Y
    Stat Methods Med Res; 2020 Oct; 29(10):2865-2880. PubMed ID: 32281490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penalized integrative semiparametric interaction analysis for multiple genetic datasets.
    Li Y; Li R; Lin C; Qin Y; Ma S
    Stat Med; 2019 Jul; 38(17):3221-3242. PubMed ID: 30993736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust analysis of cancer heterogeneity for high-dimensional data.
    Cheng C; Feng X; Li X; Wu M
    Stat Med; 2022 Nov; 41(27):5448-5462. PubMed ID: 36117143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative gene set analysis of multi-platform data with sample heterogeneity.
    Hu J; Tzeng JY
    Bioinformatics; 2014 Jun; 30(11):1501-7. PubMed ID: 24489370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor analysis for survival time prediction with informative censoring and diverse covariates.
    McCurdy S; Molinaro A; Pachter L
    Stat Med; 2019 Sep; 38(20):3719-3732. PubMed ID: 31162708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection.
    Mayr A; Hofner B; Schmid M
    BMC Bioinformatics; 2016 Jul; 17():288. PubMed ID: 27444890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating multiple molecular sources into a clinical risk prediction signature by extracting complementary information.
    Hieke S; Benner A; Schlenl RF; Schumacher M; Bullinger L; Binder H
    BMC Bioinformatics; 2016 Aug; 17(1):327. PubMed ID: 27578050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.